Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC weekly Stock Chart
AZN [NYSE]
AstraZeneca PLC
Index- P/E104.20 EPS (ttm)0.52 Insider Own0.50% Shs Outstand2.63B Perf Week0.69%
Market Cap141.46B Forward P/E21.72 EPS next Y2.48 Insider Trans0.00% Shs Float2.60B Perf Month0.75%
Income1.34B PEG5.57 EPS next Q0.46 Inst Own18.30% Short Float0.14% Perf Quarter11.35%
Sales24.38B P/S5.80 EPS this Y-39.70% Inst Trans-0.51% Short Ratio0.68 Perf Half Y12.49%
Book/sh5.00 P/B10.77 EPS next Y26.21% ROA2.20% Target Price52.80 Perf Year40.43%
Cash/sh2.37 P/C22.75 EPS next 5Y18.70% ROE10.80% 52W Range36.15 - 57.44 Perf YTD8.04%
Dividend1.40 P/FCF- EPS past 5Y1.00% ROI8.30% 52W High-6.22% Beta0.59
Dividend %2.60% Quick Ratio0.70 Sales past 5Y-1.70% Gross Margin80.10% 52W Low49.02% ATR1.49
Employees70600 Current Ratio0.90 Sales Q/Q3.80% Oper. Margin12.00% RSI (14)55.90 Volatility2.50% 2.22%
OptionableYes Debt/Eq1.39 EPS Q/Q-70.80% Profit Margin5.50% Rel Volume0.84 Prev Close55.00
ShortableYes LT Debt/Eq1.24 EarningsApr 29 BMO Payout280.10% Avg Volume5.33M Price53.87
Recom1.50 SMA20-0.26% SMA507.67% SMA20013.27% Volume4,455,360 Change-2.05%
Nov-22-19Initiated SVB Leerink Outperform
Oct-25-19Upgrade Liberum Hold → Buy
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-04-20 10:37PM  
04:13PM  
03:37PM  
02:42PM  
02:16PM  
11:38AM  
11:27AM  
10:23AM  
10:15AM  
08:13AM  
07:19AM  
02:47AM  
02:10AM  
01:28AM  
Jun-03-20 06:04PM  
03:07PM  
01:03PM  
11:56AM  
07:02AM  
Jun-02-20 10:53AM  
09:43AM  
08:00AM  
Jun-01-20 01:58PM  
11:49AM  
10:03AM  
09:20AM  
07:50AM  
07:00AM  
03:01AM  
02:15AM  
02:00AM  
May-31-20 05:32PM  
May-29-20 04:14PM  
12:19PM  
10:29AM  
09:37AM  
09:13AM  
08:38AM  
08:01AM  
08:01AM  
08:00AM  
08:00AM  
08:00AM  
06:06AM  
03:31AM  
02:00AM  
May-28-20 09:05PM  
05:00PM  
11:01AM  
10:56AM  
09:39AM  
12:00AM  
May-27-20 12:31PM  
12:07PM  
12:00AM  
May-26-20 11:53AM  
10:53AM  
10:52AM  
09:59AM  
08:00AM  
May-25-20 02:35AM  
May-24-20 02:40PM  
01:39PM  
08:21AM  
May-23-20 05:22PM  
May-22-20 03:49PM  
03:44PM  
11:56AM  
10:31AM  
09:22AM  
07:29AM  
07:29AM  
07:00AM  
06:16AM  
05:58AM  
05:37AM  
02:51AM  
12:43AM  
May-21-20 07:04PM  
05:01PM  
04:49PM  
04:22PM  
04:21PM  
03:48PM  
03:25PM  
02:24PM  
01:48PM  
12:55PM  
12:40PM  
11:34AM  
11:27AM  
10:10AM  
09:48AM  
09:36AM  
09:15AM  
07:14AM  
06:08AM  
04:40AM  
04:23AM  
04:22AM  
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 07Buy19.00425,0008,075,00014,650,334Oct 09 04:53 PM